CytoTronics enables optics-free imaging for drug discovery through its complementary metal-oxide-semiconductor (CMOS) electronics platform. Building upon a suite of innovations licensed from Harvard University, CytoTronics’s technology measures and manipulates live cells to produce real-time, high resolution electrical and electrochemical cell-based assays. By providing unique single-cell resolution readouts that are not currently available in today’s cell-based drug screening market, CytoTronics is enhancing the accuracy of cell-biology information that can be used to revolutionize drug discovery.
Location: United States, Massachusetts, Boston
Member count: 11-50
Total raised: $9.25M
Founded date: 2020
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 30.04.2022 | Seed | $9.25M | Anzu Partn... | finsmes.co... |
Mentions in press and media 4
| Date | Title | Description | Category | Author | Source |
| 30.04.2022 | CytoTronic... | Harvard University spinout adv... | - | - | aithority.... |
| 29.04.2022 | CytoTronic... | CytoTronics, a Boston, MA-base... | USA | - | finsmes.co... |
| 28.04.2022 | CytoTronic... | BOSTON, MA, CytoTronics toda... | - | - | vcnewsdail... |
| 28.04.2022 | Has Elon M... | This is the web version of Ter... | - | - | fortune.co... |